Expanding the definition of AMD
August 02, 2021
Why investigators are recognising AMD as a disease spectrum rather than a single entity.
© 2021 MJH Life Sciences™ and Opthalmology Times Europe. All rights reserved.
All Articles
Application for Genentech’s faricimab accepted by U.S. FDA for treatment of wet AMD and DMO
August 03, 2021
If approved, Genentech’s treatment of faricimab will be the first and only medicine targeting two distinct pathways, Ang-2 and VEGF-A, that often cause retinal diseases that may cause vision loss.
Combined MIGS and cataract surgery option offers positive results
July 29, 2021
Retrospective review highlights the sustained efficacy of combination procedure.
Study evaluates periodic aflibercept injections in NPDR treatment
July 27, 2021
The proportion of eyes that developed PDR or centre-involving DMO was lower with periodic aflibercept treatments compared with sham treatment through the 2-year point.
Pearls for ocular surgical success in patients with chronic uveitis
July 21, 2021
While operating on a patient with chronic uveitis presents some challenges, there are a few pearls that may increase success.
Dropless glaucoma treatment: An elusive path to ease burden
July 19, 2021
Ophthalmologists should consider numerous options for treating individual glaucoma patients, including non-medical interventions.
The impact of landmark studies on clinical practice in glaucoma
July 12, 2021
Landmark randomised controlled trials have advanced the understanding and treatment of glaucoma.
BELKIN Laser rebrands as BELKIN Vision
July 08, 2021
The glaucoma treatment company rebrands to align more closely with goals and direction of the company.
Royal College of Surgeons of Edinburgh launches MRCS ophthalmology exam, Fellowship to follow
July 07, 2021
A new MRCS ophthalmology examination will be offered to ICO College Members beginning in 2022.
Shedding light on Horner’s syndrome
July 06, 2021
Investigators found that 56.4% of Horner’s syndrome cases resulted from a dangerous cause.